CAT-BP

  • Research type

    Research Study

  • Full title

    Assessing patterns, barriers and facilitators of antihypertensive medication non-adherence in diverse populations with multiple long-term cardiometabolic conditions (CAT-BP)

  • IRAS ID

    350792

  • Contact name

    Patrick Highton

  • Contact email

    ph204@le.ac.uk

  • Sponsor organisation

    University of Leicester

  • Duration of Study in the UK

    1 years, 11 months, 30 days

  • Research summary

    People who take medications to lower their blood pressure often struggle to take these medications regularly; this is called medication non-adherence. This means that these people may be at higher risk for future heart problems, and also that medications are being wasted, which is expensive for the NHS. These risks may be even higher in those from ethnic minority backgrounds or people who are more socioeconomically deprived.

    People with low medication adherence often struggle to talk to their doctor about it, and so the doctor is not aware. A new test has been developed that can detect medications in urine, to assess whether those medications have been taken. This is called chemical adherence testing (CAT). The doctor can then discuss this with the patient, and find a way to support them to take their medications more regularly. However, it is not yet known how well this test will be perceived by patients from diverse or deprived areas as this has not been investigated. It is important to test this to make sure everyone has the same opportunity to benefit in the future.

    Therefore, this study will investigate the use of the test in practices that have diverse patient populations and/or are in socioeconomically deprived areas. People with hypertension who are showing signs of being nonadherent will be asked to participate. We will take a urine sample from these people to test for their adherence, and we will also collect some routine data from their healthcare record and ask them to fill out some questionnaires. There will also be an extra optional element to the study where we will ask people to complete an interview or focus group discussion about their experiences of the test and their medication adherence.

  • REC name

    Yorkshire & The Humber - South Yorkshire Research Ethics Committee

  • REC reference

    25/YH/0036

  • Date of REC Opinion

    11 Mar 2025

  • REC opinion

    Further Information Favourable Opinion